BAM
Barrett Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $2.9M | Buy |
4,152
+14
| +0.3% | +$9.78K | 0.12% | 78 |
|
|
2021
Q4 | $2.61M | Buy |
4,138
+693
| +20% | +$438K | 0.1% | 83 |
|
|
2021
Q3 | $2.09M | Sell |
3,445
-116
| -3% | -$70.2K | 0.1% | 82 |
|
|
2021
Q2 | $1.99M | Buy |
3,561
+275
| +8% | +$154K | 0.09% | 84 |
|
|
2021
Q1 | $1.56M | Buy |
3,286
+316
| +11% | +$150K | 0.08% | 92 |
|
|
2020
Q4 | $1.44M | Buy |
2,970
+94
| +3% | +$45.4K | 0.08% | 86 |
|
|
2020
Q3 | $1.61M | Buy |
2,876
+461
| +19% | +$258K | 0.1% | 79 |
|
|
2020
Q2 | $1.51M | Buy |
2,415
+915
| +61% | +$571K | 0.1% | 73 |
|
|
2020
Q1 | $732K | Hold |
1,500
| – | – | 0.06% | 92 |
|
|
2019
Q4 | $563K | Buy |
+1,500
| New | +$563K | 0.03% | 106 |
|
|
2018
Q1 | – | Sell |
-75
| Closed | -$28K | – | 399 |
|
|
2017
Q4 | $28K | Buy |
+75
| New | +$28K | ﹤0.01% | 292 |
|